Skip to content
My WebMD Sign In, Sign Up

Hodgkin Lymphoma: What if My Transplant Doesn't Work?

Craig H. Moskowitz, MD, Professor of Medicine, Weill Cornell Medical College

|Disclosures|May 29, 2015
 

 
 

 

References

  1. Kuruvilla J, Keating A, Crump M. How I treat relapsed and refractory Hodgkin lymphoma. Blood. 2011;117:4208-4217.

  2. US Food and Drug Administration. Brentuximab vedotin. www.fda.gov/AboutFDA/CentersOffices/OfficeofMedicalProductsandTobacco/CDER/ucm268969.htm. Accessed April 16, 2015.

  3. Graf SA, Gopal AK. Treatment of relapsed classical Hodgkin lymphoma in the brentuximab vedotin era. Hematology AM Soc Hematol Educ Program. 2014;2014:151-157.

  4. Ansell SM, Lesokhin AM, Borrello I, et al. PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma. N Engl J Med. 2015;372:311-319.

Authors and Disclosures

Author(s)

Craig H. Moskowitz, MD

Professor of Medicine, Weill Cornell Medical College; Clinical Director, Division Of Hematologic Oncology; Attending Physician, Lymphoma and Adult Bone Marrow Transplant (ABMT) Service, Memorial Sloan Kettering Cancer Center, New York, New York

Disclosure: Craig H. Moskowitz, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Merck & Co., Inc.; Seattle Genetics, Inc.

Dr Moskowitz does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

Dr Moskowitz does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Editor

Kristin Richardson

Lead Scientific Director, Medscape, LLC

Disclosure: Kristin Richardson has disclosed no relevant financial relationships.

Writer

Clare Karten, MS

Freelance Writer, Hartsdale, New York

Disclosure: Clare Karten, MS, has disclosed no relevant financial relationships.

CME Reviewer

Nafeez Zawahir, MD

CME Clinical Director, Medscape, LLC

Disclosure: Nafeez Zawahir, MD, has disclosed no relevant financial relationships.

Print
URAC: Accredited Health Web Site HonCode: Health on the Net Foundation AdChoices